347 related articles for article (PubMed ID: 10946410)
1. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
[TBL] [Abstract][Full Text] [Related]
2. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.
Saracino A; Di Stefano M; Fiore JR; Lepera A; Raimondi D; Angarano G; Pastore G
New Microbiol; 2000 Jan; 23(1):79-83. PubMed ID: 10946409
[TBL] [Abstract][Full Text] [Related]
3. Correlates of human immunodeficiency virus cervicovaginal shedding among postmenopausal and fertile-aged women.
Melo KC; Melo MR; Ricci BV; Segurado AC
Menopause; 2012 Feb; 19(2):150-6. PubMed ID: 21983010
[TBL] [Abstract][Full Text] [Related]
4. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus in plasma and cervicovaginal secretions in Filipino women.
Natividad-Villanueva GU; Santiago E; Manalastas RM; Brown HW; Ingersoll J; Caliendo AM; Mayer KH; Cu-Uvin S
Int J STD AIDS; 2003 Dec; 14(12):826-9. PubMed ID: 14678591
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand.
Chuachoowong R; Shaffer N; VanCott TC; Chaisilwattana P; Siriwasin W; Waranawat N; Vanprapar N; Young NL; Mastro TD; Lambert JS; Robb ML
J Infect Dis; 2000 Jun; 181(6):1957-63. PubMed ID: 10837175
[TBL] [Abstract][Full Text] [Related]
8. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.
Bélec L; Ghys PD; Hocini H; Nkengasong JN; Tranchot-Diallo J; Diallo MO; Ettiègne-Traore V; Maurice C; Becquart P; Matta M; Si-Mohamed A; Chomont N; Coulibaly IM; Wiktor SZ; Kazatchkine MD
J Infect Dis; 2001 Dec; 184(11):1412-22. PubMed ID: 11709783
[TBL] [Abstract][Full Text] [Related]
9. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission.
Panther LA; Tucker L; Xu C; Tuomala RE; Mullins JI; Anderson DJ
J Infect Dis; 2000 Feb; 181(2):555-63. PubMed ID: 10669339
[TBL] [Abstract][Full Text] [Related]
10. Enterovirus RNA shedding in the genital tract of childbearing-aged women living in Central Africa.
Jacques J; Bélec L; Moret H; Grésenguet G; Longo Jde D; Chomont N; Brodard V; Matta M; Graesslin O; Andréoletti L
J Med Virol; 2006 May; 78(5):591-7. PubMed ID: 16555273
[TBL] [Abstract][Full Text] [Related]
11. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.
Coombs RW; Wright DJ; Reichelderfer PS; Burns DN; Cohn J; Cu-Uvin S; Baron PA; Cohen MH; Landay AL; Lewis S; Kovacs A;
J Infect Dis; 2001 Nov; 184(9):1187-91. PubMed ID: 11598843
[TBL] [Abstract][Full Text] [Related]
12. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
Akagi T; Kawamura M; Ueno M; Hiraishi K; Adachi M; Serizawa T; Akashi M; Baba M
J Med Virol; 2003 Feb; 69(2):163-72. PubMed ID: 12683403
[TBL] [Abstract][Full Text] [Related]
14. Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions.
Bard E; Riethmuller D; Biichlé S; Meillet D; Prétet JL; Mougin C; Seillès E
J Immunoassay Immunochem; 2002; 23(2):145-62. PubMed ID: 12033640
[TBL] [Abstract][Full Text] [Related]
15. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.
Haimovici F; Mayer KH; Anderson DJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):185-91. PubMed ID: 9257652
[TBL] [Abstract][Full Text] [Related]
17. Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.
Mestecky J; Wright PF; Lopalco L; Staats HF; Kozlowski PA; Moldoveanu Z; Alexander RC; Kulhavy R; Pastori C; Maboko L; Riedner G; Zhu Y; Wrinn T; Hoelscher M
AIDS Res Hum Retroviruses; 2011 May; 27(5):469-86. PubMed ID: 21091128
[TBL] [Abstract][Full Text] [Related]
18. Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India.
Khopkar P; Sane S; Bichare S; Verma A; Kulkarni S
J Clin Virol; 2013 Dec; 58(4):730-2. PubMed ID: 24238888
[TBL] [Abstract][Full Text] [Related]
19. Mucosal HIV-binding antibody and neutralizing activity in high-risk HIV-uninfected female participants in a trial of HIV-vaccine efficacy.
Schneider JA; Alam SA; Ackers M; Parekh B; Chen HY; Graham P; Gurwith M; Mayer K; Novak RM
J Infect Dis; 2007 Dec; 196(11):1637-44. PubMed ID: 18008247
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
